Characterization of Hprt Mutations in cDNA and Genomic DNA of T-Cell Mutants from Control and 1,3-Butadiene-Exposed Male B6C3F1 Mice and F344 Rats

Environmental and Molecular Mutagenesis

Volumn 43, Issue 2, 2004, Pages 75-92

  Meng, Quanxin ^a,c   Walker, Dale M ^a   Scott, Bobby R ^a   Seilkop, Steve K ^b   Aden, James K ^a   Walker, Vernon E ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b SKS Consulting Services   (United States)

^c BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

1,3 butadiene; Hprt; Multiplex PCR; RT PCR; T cell mutagenesis

Indexed keywords

1,3 BUTADIENE; ADENINE; COMPLEMENTARY DNA; CYTOSINE; DNA; GUANINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; RNA; THYMINE;

ANIMAL EXPERIMENT; ARTICLE; BASE MISPAIRING; CONTROLLED STUDY; DNA SEQUENCE; GENE; GENE MUTATION; MALE; MOUSE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANIMALS; BUTADIENES; DNA; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MALE; MICE; MICE, INBRED STRAINS; MUTAGENS; MUTATION; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

ANIMALIA; RODENTIA;

EID: 1542513947     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.20002     Document Type: Article

References (50)

1. Albertini RJ. 2001. HPRT mutations in humans: biomarkers for mechanistic studies. Mutat Res:1-16.
2. Albertini RJ, Šrám RJ, Vacek PM, Lynch J, Nicklas JA, van Sittert NJ, Boogaard PJ, Henderson RJ, Swenberg JA, Tates AD, Ward JB Jr, Wright M, and others. 2003. Biomarkers in Czech workers exposed to 1,3-butadiene: a translational epidemiologic study. HEI Research No. 116. Montpelier, VT: Health Effects Institute, Capital City Press.
3. Chen C, Yang MC, Yang TP. 2001. Evidence that silencing of the HPRT promoter by DNA methylation is mediated by critical CpG sites. J Biol Chem 276:320-328.
4. Chen T, Aidoo A, Casciano DA, Heflich RH. 1998. Expansion of rat 6-thioguanine-resistant T-lymphocyte clones by stimulation with ionomycin and a phorbol ester. Environ Mol Mutagen 31:97-102.
5. Chen T, Aidoo A, Mittelstaedt R, Casicano DA, Heflich RH. 1999. Hprt mutant frequency and molecular analysis of Hprt mutations in Fischer 344 rats treated with thiotepa. Carcinogenesis 20:269-277.
6. Cochrane JE, Skopek TR. 1994a. Mutagenicity of butadiene and its epoxide metabolites. I. mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis 15:713-717.
7. Cochrane JE, Skopek TR. 1994b. Mutagenicity of butadiene and its epoxide metabolites. II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice. Carcinogenesis 15:719-723.
8. Fink D, Aebi S, Howell SB. 1998. The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4:1-6.
9. Freeman GH, Halton JH. 1951. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 38:141-149.
10. Gibbs AR, Nguyen PN, Edwards A, Civitello AB, Caskey CT. 1990. Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families. Genomics 7:235-244.
11. Goodrow T, Reynolds S, Maronpot R, Anderson M. 1990. Activation of K-ras by codon 13 mutations in C57BL/6 x C3HF1 mouse tumors induced by exposure to 1,3-butadiene. Cancer Res 50:4818-4823.
12. Goodrow TL, Nichols WW, Storer RD, Anderson MC, Maronpot RR. 1994. Activation of H-ras is prevalent in 1,3-butadiene-induced and spontaneously occurring Harderian gland tumors. Carcinogenesis 15:2665-2667.
13. Guthrie EP, Quinton-Jager T, Moran LS, Slatko BE, Kucera RB, Benner JS, Wilson GG, Brooks JE. 1996. Cloning, expression and sequence analysis of the SphI restriction-modification system. Gene 180:107-112.
14. Himmelstein MW, Turner MJ, Asgharian B, Bond JA. 1994. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogenesis 15:1479-1486.
15. Himmelstein MW, Asgharian B, Bond JA. 1995. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene. Toxicol Appl Pharmacol 132:281-288.
16. Himmelstein MW, Turner MJ, Asgharian B, Bond JA. 1996. Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice. Toxicology 113:306-309.
17. Hong HL, Devereux TR, Melnick RL, Eldridge SR, Greenwell A, Haseman J, Boorman GA, Sills RC. 1997. Both K-ras and H-ras protooncogene mutations are associated with Harderian gland tumorigenesis in B6C3F1 mice exposed to isoprene for 26 weeks. Carcinogenesis 18:783-789.
18. Huff JE, Melnick RL, Solleveld HA, Haseman JK, Powers M, Miller RA. 1985. Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science 227:548-549.
19. Intemational Agency for Research on Cancer (IARC). 1992. 1,3-Butadiene. In: IARC monographs on the evaluations of carcinogenic risk to humans. Vol 54. Occupational exposures to mists and vapours from strong inorganic acids; and other industrial chemicals. Lyon: IARC. p 237-285.
20. Jansen JG, Vrieling H, van Zeeland AA, Mohn GR. 1992. The gene encoding hypoxanthing-guanine phosphoribosyltransferase as target for mutational analysis: PCR cloning and sequencing of the cDNA from the rat. Mutat Res 266:104-116.
21. Lee DH, Kim TH, Lee SY, Kim HJ, Rhee SK, Yoon B, Pfeifer GP, Lee CS. 2002. Mutations by 1,3-butadiene metabolites, butadiene diolepoxide, and 1,2,3,4-diepoxybutane at the Hprt locus of CHO-K1 cells. Mol. Cells 14:411-419.
22. Lehmann EL. 1959. Testing statistical hypotheses. Section 4.5. New York: John Wiley & Sons.
23. Ma H, Wood TG, Ammenheuser MM, Rosenblatt JI, Ward JB Jr. 2000. Molecular analysis of hprt mutant lymphocytes from 1,3-butadiene-exposed workers. Environ Mol Mutagen 36:59-71.
24. Melnick RL, Huff J, Chou BJ, Miller RA. 1990. Carcinogenicity of 1,3-butadiene in C57BL/6xC3H F1 mice at low exposure concentrations. Cancer Res 50:6592-6599.
25. Melton DW, Konecki DS, Brennard J, Caskey CT. 1984. Structure, expression, and mutation of the hypoxanthine-guanine phosphoribosyltransferase gene. Proc Natl Acad Sci USA 81:2147-2151.
26. Meng Q, Skopek TR, Walker DM, Hurley-Leslie S, Chen T, Zimmer DM, Walker VE. 1998a. Culture and propagation of Hprt mutant T-lymphocytes isolated from mouse spleen. Environ Mol Mutagen 32:236-243.
27. Meng Q, Recio L, Reilly AA, Wong BA, Bauer M, Walker VE. 1998b. Comparison of the mutagenic potency of 1,3-butadiene at the hprt locus of T-lymphocytes following inhalation exposure of female B6C3F1 mice and F344 rats. Carcinogenesis 19:1019-1027.
28. Meng Q, Henderson RF, Chen T, Heflich RH, Walker DM, Bauer M, Reilly AA, Walker VE. 1999a. Mutagenicity of 1,3-butadiene at the hprt locus of T-cells following inhalation exposures of female mice and rats. Mutat Res 429:107-125.
29. Meng Q, Henderson RF, Walker DM, Bauer MJ, Reilly AA, Walker VE. 1999b. Mutagenicity of the racemic mixtures of butadiene monoepoxide and butadiene diepoxide at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats. Mutat Res 429:127-140.
30. Meng Q, Singh N, Heflich RH, Bauer MJ, Walker VE. 2000. Comparison of the mutations at Hprt exon 3 of T-lymphocytes from B6C3F1 mice and F344 rats exposed by inhalation to 1,3-butadiene or the racemic mixture of 1,2:3,4-diepoxybutane. Mutat Res 464:169-184.
31. Meng Q, Henderson RF, Long L, Blair L, Walker DM, Upton PB, Swenberg JA, Walker VE. 2001. Mutagenicity at the Hprt locus in T-cells of female mice following inhalation exposures to low levels of 1,3-butadiene. Chem Biol Interact 135/136:343-361.
32. Meng Q, Henderson RJ, Walker VE. 2003. Age-, gender-, and species-dependent mutagenicity in T-cells from mice and rats exposed by inhalation to 1,3-butadiene. Mutat. Res (submitted).
33. National Research Council (NRC). 1996. Guide of the care of and use of laboratory animals. Washington, DC: National Academy Press.
34. Owen PE, Glaiser RJ, Gaunt IF, Pullinger DH. 1987. Inhalation toxicity studies with 1,3-butadiene. Two-year toxicity/carcinogenicity study in rats. Am Ind Hyg Assoc J 48::407-413.
35. Park S, Tretyakova N. 2003. Structural characterization of the major DNA-DNA cross-link of diepoxybutane. Chem Res Toxicol, submitted.
36. Recio L, Sisk S, Meyer K, Pluta L, Bond JA. 1996. Mutagenicity and mutational spectra of 1,3-butadiene in the bone marrow of B6C3F1 lacI transgenic mice. Toxicology 113:106-111.
37. Recio L, Steen AM, Pluta LJ, Meyer KG, Saranko CJ. 2001. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms. Chem Biol Interact 135/136:325-341.
38. Saranko CJ, Meyer KG, Pluta LJ, Henderson RF, Recio L. 2001. Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene. Mutat Res 473:37-49.
39. Sills RC, Hong HL, Melnick RL, Boorman GA, Devereux TR. 1999. High frequency of codon 61 K-ras A→T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene. Carcinogenesis 20:657-662.
40. Sills RC, Hong HL, Boorman GA, Devereux TR, Melnick RL. 2001. Point mutations of K-ras and H-ras genes in forestomach neoplasms from control B6C3F1 mice and following exposure to 1-3,butadiene, isoprene or chloroprene for up to 2 years. Chem Biol Interact 135/136:373-386.
41. Steen AM, Meyer KG, Recio L. 1997a. Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1,2,3,4-diepoxybutane. Mutagenesis 12:61-67.
42. Steen AM, Meyer KG, Recio L. 1997b. Characterization of hprt mutations following 1,2-epoxy-3-butene exposure of human TK6 cells. Mutagenesis 12:359-364.
43. Swenberg JA, Koc H, Upton PB, Georguieva N, Ranasinghe A, Walker VE, Henderson R. 2001. Using DNA and hemoglobin adducts to improve the risk assessment of butadiene. Chem Biol Interact 135/136:378-403.
44. Thornton-Manning JR, Dahl AR, Bechtold WE, Griffith WC Jr, Henderson RF. 1995a. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis 16:1723-1731.
45. Thornton-Manning JR, Dahl AR, Bechtold WE, Griffith WC Jr, Pei L, Henderson RF. 1995b. Gender differences in the metabolism of 1,3-butadiene in Sprague-Dawley rats following a low-level inhalation exposure. Carcinogenesis 16:2875-2878.
46. Thornton-Manning JR, Dahl AR, Bechtold WE, Henderson RF. 1996. Gender and species differences in the metabolism of 1,3-butadiene to butadiene monoepoxide and butadiene diepoxide in rodents following low-level inhalation exposures. Toxicology 113:322-325.
47. Walker VE, Skopek TR. 1993. A mouse model for the study of in vivo mutational spectra: sequence specificity of ethylene oxide at the hprt locus. Mutat Res 288:151-162.
48. Walker VE, Meng Q, Walker DM, McDonald J, Scott BR, Bauer MJ, Claffey DJ, Upton PB, Swenberg JA, Henderson RF. 2003. Genotoxicity of 1,3-butadiene and its epoxy intermediates. Montpelier, VT: HEI Research, Health Effects Institute, Capital City Press (submitted).
49. Zhuang S-M, Cochran C, Goodrow T, Wiseman RW, Söderkvist P. 1997. Genetic alterations of p53 and ras genes in 1,3-butadiene- and 2′,3′-dideoxycytidine-induced lymphomas. Cancer Res 57:2710-2714.
50. Zhuang S-M, Wiseman RW, Soderkvist P. 2002. Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice. Oncogene 21:5643-5648.